Related Experiment Video
Updated: Apr 5, 2026

Author Spotlight: Exploring the Mechanisms of MicroRNA Loading into Extracellular Vesicles in Cancer Progression
Published on: October 6, 2023
Membrane microparticles: shedding new light into cancer cell communication
Paloma Silva de Souza1, Roberta Soares Faccion1, Paula Sabbo Bernardo2
1Laboratório de Hemato-Oncologia Celular e Molecular, Programa de Hemato-Oncologia Molecular, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.
Background:
Microparticles (MPs) or ectosomes are small enclosed fragments (from 0.2 to 2 μm in diameter) released from the cellular plasma membrane. Several oncogenic molecules have been identified inside MPs, including soluble proteins XIAP, survivin, metalloproteinases, CX3CL1, PYK2 and other microRNA-related proteins; membrane proteins EGFR, HER-2, integrins and efflux pumps; and messenger RNAs and microRNAs miR-21, miR-27a, let-7, miR-451, among others. Studies have shown that MPs transfer their cargo to neoplastic or non-malignant cells and thus contribute to activation of oncogenic pathways, resulting in cell survival, drug resistance and cancer dissemination.
Discussion And Conclusion:
This review summarizes recent findings on MP biogenesis and the role of the MPs cargo in cancer and discusses some of the RNAs and proteins involved. In addition, the discussion covers evidence of (1) how and which signaling pathways can be activated by MPs in recipient cells; (2) recipient cell-type selectivity in incorporation of proteins and RNAs transported by MPs; and (3) how upon stimulation, stromal cells release MPs, promoting resistance to chemotherapeutics and invasiveness in cancer cells.
Insights
Microparticles (MPs), small cell fragments, carry oncogenic molecules that promote cancer progression and drug resistance. This review details MP cargo, their role in activating cancer pathways, and their impact on treatment resistance.
Area of Science:
- Cell biology
- Cancer research
- Molecular oncology
Background:
- Microparticles (MPs) are cell-derived vesicles containing oncogenic proteins and nucleic acids.
- MPs facilitate intercellular transfer of cancer-promoting molecules.
- These molecules contribute to cancer cell survival, drug resistance, and metastasis.
Purpose of the Study:
- To review current knowledge on MP biogenesis and their role in cancer.
- To discuss specific RNA and protein cargo within MPs.
- To explore MP-mediated signaling in recipient cells and their impact on cancer progression and treatment.
Main Methods:
- Literature review of studies on microparticles in cancer.
- Analysis of identified oncogenic molecules within MPs (proteins, mRNAs, microRNAs).
- Examination of MP cargo transfer and its effects on recipient cells and cancer pathways.
Main Results:
- MPs contain diverse oncogenic cargo, including proteins like XIAP and survivin, and microRNAs such as miR-21.
- MPs transfer cargo to various cell types, activating oncogenic pathways.
- Stromal cell-derived MPs can induce chemoresistance and invasiveness in cancer cells.
Conclusions:
- MPs play a significant role in cancer development and progression.
- Understanding MP cargo and biogenesis is crucial for cancer therapy.
- MPs represent a potential therapeutic target for overcoming drug resistance and metastasis.
More Related Videos
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Cell Migration through Invadopodia
The Tumor Microenvironment
Cell-surface Signaling

